Docoh
Loading...
Sign up Log in

KRMD Repro-Med Systems

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.

Company profile

Ticker
KRMD
Exchange
NASDAQ
Website
www.korumedical.com
CEO
Donald B. Pettigrew
Employees
Incorporated
New York
Location
New York
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Boston Scientific • Baxter International • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...
SEC CIK
0000704440
Corporate docs
IRS number
133044880

KRMD stock data

(
)

News

Pro users get this 30m faster
12 Health Care Stocks Moving In Tuesday's After-Market Session
18 May 21
Gainers
77 Biggest Movers From Yesterday
14 May 21
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52.
12 Health Care Stocks Moving In Thursday's Intraday Session
13 May 21
Recap: Repro-Med Systems Q1 Earnings
12 May 21
Repro-Med Systems Q1 EPS $(0.03) Misses $(0.01) Estimate, Sales $5.40M Beat $5.10M Estimate
12 May 21

Press releases

Pro users get this 30m faster
KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021
28 Jul 21
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and
Lifshitz Law Firm, P.C. Announces Investigations of, CleanSpark, Inc. (NasdaqGS: CLSK), The Geo Group, Inc. (NYSE: GEO), Repro Med Systems, Inc. (NasdaqGS: KRMD), and Romeo Power, Inc. (NYSE: RMO)
28 Jun 21
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- CleanSpark, Inc. (NASDAQ:CLSK) Lifshitz Law Firm, P.C. announces that a class action complaint was filed against CLSK alleging that CLSK failed to disclose to investors:
KRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 25, 2021 in the Class Action Filed on Behalf of Repro Med Systems, Inc. Limited Shareholders
25 May 21
New York, New York--(Newsfile Corp. - May 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Repro Med Systems, Inc. (NASDAQ:KRMD) alleging that the Company
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Repro Med Systems, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 25, 2021 - KRMD
25 May 21
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
25 May 21

Calendar

12 May 21
3 Aug 21
31 Dec 21

Financial summary

Financial statements Chart KRMD financial data
Quarter (USD)
 Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Dec 20 Dec 19 Dec 18 Feb 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 26.77M 26.77M 26.77M 26.77M 26.77M 26.77M
Cash burn (monthly) 180.19K (positive/no burn) 737.76K 337.57K 868.55K 291.85K
Cash used (since last report) 744.77K n/a 3.05M 1.4M 3.59M 1.21M
Cash remaining 26.03M n/a 23.73M 25.38M 23.18M 25.57M
Runway (months of cash) 144.5 n/a 32.2 75.2 26.7 87.6

Beta Read what these cash burn values mean

Recent insider trades

KRMD insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jun 21 Manko Joseph M. Jr. Common Stock Grant Aquire A Yes No 0 2,263 0 7,462,039
30 Jun 21 Allen Robert T Common Stock Grant Aquire A No No 4.63 2,263 10.48K 16,642
30 Jun 21 Anderson David W Common Stock Grant Aquire A No No 4.63 2,263 10.48K 43,262
30 Jun 21 Beck James M Common Stock Grant Aquire A No No 4.63 2,100 9.72K 52,096
30 Jun 21 Fletcher R John Common Stock Grant Aquire A No No 4.63 3,744 17.33K 86,734
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

KRMD institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

82.8% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 72 75 -4.0%
Opened positions 15 14 +7.1%
Closed positions 18 29 -37.9%
Increased positions 24 31 -22.6%
Reduced positions 24 22 +9.1%
13F shares
 Current Prev Q Change
Total value 349.55M 163.78M +113.4%
Total shares 36.85M 27.21M +35.4%
Total puts 40K 25.1K +59.4%
Total calls 40.4K 10.7K +277.6%
Total put/call ratio 1.0 2.3 -57.8%
Largest owners
 Shares Value Change
Horton Capital Partners 10.74M $37.49M NEW
Horton Capital Management 10.74M $37.81M -9.5%
First Light Asset Management 5.49M $19.31M -6.6%
Vanguard 1.71M $6.02M +4.7%
BLK Blackrock 1.67M $5.89M +5.2%
Roubaix Capital 914.03K $3.22M NEW
RY Royal Bank Of Canada 496.12K $1.75M +44.6%
MS Morgan Stanley 495.87K $1.75M +520.5%
Geode Capital Management 452.95K $1.59M +20.7%
STT State Street 423.09K $1.49M -3.8%
Largest transactions
 Shares Bought/sold Change
Horton Capital Partners 10.74M +10.74M NEW
Horton Capital Management 10.74M -1.12M -9.5%
Roubaix Capital 914.03K +914.03K NEW
Parkman Healthcare Partners 261.72K -439.54K -62.7%
MS Morgan Stanley 495.87K +415.96K +520.5%
Fuller & Thaler Asset Management 0 -397.49K EXIT
First Light Asset Management 5.49M -386.13K -6.6%
Millennium Management 0 -383.27K EXIT
DB Deutsche Bank AG - Registered Shares 355.75K +335.46K +1653.1%
Schonfeld Strategic Advisors 83K -318K -79.3%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Additionally, advisor, Allen, automatically, Beck, channel, compensatory, core, counsel, departure, enterprise, failed, false, iii, infrastructure, Linda, merit, misleading, multiplying, Notwithstanding, patient, pharmaceutical, plaintiff, proper, regular, repurchase, resigned, Robert, run, secondary, slightly, slowdown, Tharby, thirty
Removed: accelerated, adding, adjusted, administered, affecting, Aid, awarded, brought, build, building, built, Carpenter, case, certificate, chain, chair, claim, closely, collateral, collateralized, comparable, compare, comparison, consisting, consulting, continuing, creating, criterion, Daniel, define, depending, deposit, determining, disclosing, discontinuation, dismissed, distancing, distribution, drew, earned, easily, EBITDA, economic, eighteen, enhanced, evaluate, evolve, exclude, excluding, execute, executed, executing, expanded, experience, explained, failure, Fletcher, forecasting, found, fourth, fund, funded, gain, generated, generating, geographic, global, Goldberger, governmental, headcount, historically, Hizentra, immunoglobulin, impacting, implementation, incur, initiative, John, leased, maintenance, Manuel, marketing, matured, meaningfully, meant, monitoring, National, neurology, obsolescence, offered, ongoing, OTCQX, outbreak, overtime, pace, Pastreich, Paycheck, planning, plasma, policy, potential, PPP, predicted, Protection, public, reconciliation, record, recruiting, recur, reduce, released, relied, renew, renewal, reorganization, reserve, response, resulted, Road, role, senior, show, significantly, situation, size, social, solid, spread, staffing, substitute, superior, supplement, thereto, travel, twenty, understanding, understood, viewed, vital, workforce, world
From filing 10-Q 2021 Q1

Financial reports

View all
10-Q
2021 Q1
Quarterly report
12 May 21
10-K
2020 FY
Annual report
23 Mar 21
10-Q
2020 Q3
Quarterly report
12 Nov 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
4 Mar 20
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
7 May 19
10-K
2018 FY
Annual report
5 Mar 19

Current reports

View all
8-K
Submission of Matters to a Vote of Security Holders
19 May 21
8-K
Koru Medical Systems Announces 2021 First Quarter Financial Results
12 May 21
8-K
KORU Medical Systems Reports Fourth Quarter and Full Year 2020 Financial Results
23 Mar 21
8-K
KORU Medical Systems Announces New Chief Executive Officer
19 Mar 21
8-K
Departure of Directors or Certain Officers
11 Feb 21
8-K
Announces CEO Transition
25 Jan 21
8-K
Regulation FD Disclosure
17 Nov 20
8-K
Koru Medical Systems Announces Stock Repurchase Program
16 Nov 20
8-K
Koru Medical Systems Announces Financial Results for Third Quarter 2020
3 Nov 20
8-K
Koru Medical Systems Announces 2020 Second Quarter Financial Results
4 Aug 20

Registration and prospectus

View all
424B5
Prospectus supplement for primary offering
22 Jun 20
424B5
Prospectus supplement for primary offering
18 Jun 20
S-3
Shelf registration
14 May 20
424B3
Prospectus supplement
12 Mar 20
POS AM
Prospectus update (post-effective amendment)
4 Mar 20
424B3
Prospectus supplement
25 Feb 20
424B3
Prospectus supplement
24 Jan 20
424B3
Prospectus supplement
14 Nov 19
424B3
Prospectus supplement
6 Nov 19
424B3
Prospectus supplement
5 Nov 19

Proxies

View all
DEF 14A
Definitive proxy
5 Apr 21
PRE 14A
Preliminary proxy
23 Mar 21
DEFA14A
Additional proxy soliciting materials
31 Mar 20
DEF 14A
Definitive proxy
6 Mar 20
DEFA14A
Additional proxy soliciting materials
29 Mar 19
DEF 14A
Definitive proxy
8 Mar 19
PRE 14A
Preliminary proxy
21 Feb 19
DEF 14A
Definitive proxy
12 Mar 18
DEFA14A
Additional proxy soliciting materials
16 Aug 16
DEF 14A
Definitive proxy
27 Jul 16

Other

View all
EFFECT
Notice of effectiveness
21 May 20
CORRESP
Correspondence with SEC
17 May 20
UPLOAD
Letter from SEC
17 May 20
EFFECT
Notice of effectiveness
12 Mar 20
EFFECT
Notice of effectiveness
11 Mar 19
UPLOAD
Letter from SEC
10 Mar 11
CORRESP
Correspondence with SEC
1 Mar 11
UPLOAD
Letter from SEC
22 Feb 11
UPLOAD
Letter from SEC
5 Jan 09
UPLOAD
Letter from SEC
10 Dec 08

Ownership

View all
4
REPRO MED SYSTEMS / Shahriar Matin ownership change
6 Jul 21
4
REPRO MED SYSTEMS / Daniel S Goldberger ownership change
6 Jul 21
4
REPRO MED SYSTEMS / Kathy Frommer ownership change
6 Jul 21
4
REPRO MED SYSTEMS / Donna French ownership change
6 Jul 21
4
REPRO MED SYSTEMS / R JOHN FLETCHER ownership change
6 Jul 21
4
REPRO MED SYSTEMS / James M Beck ownership change
6 Jul 21
4
REPRO MED SYSTEMS / David W Anderson ownership change
6 Jul 21
4
REPRO MED SYSTEMS / Robert T Allen ownership change
6 Jul 21
4
REPRO MED SYSTEMS / Joseph M. Jr. Manko ownership change
6 Jul 21
4
REPRO MED SYSTEMS / James M Beck ownership change
4 Jun 21

Patents

GRANT
Utility
System and method for anti-foaming needle assembly
4 May 21
Provided is a system and method for an anti-foaming needle assembly for avoiding foam generation when extracting a liquid from a vessel having a chamber with a bottom and opposite thereto an opening sealed with a penetrable and re-sealable stopper providing an inner surface above the chamber.

Transcripts

View all
2021 Q1
Earnings call transcript
12 May 21
2020 Q4
Earnings call transcript
24 Mar 21
2020 Q3
Earnings call transcript
4 Nov 20
2020 Q2
Earnings call transcript
9 Aug 20
2020 Q1
Earnings call transcript
10 May 20
2019 Q4
Earnings call transcript
26 Feb 20
2019 Q3
Earnings call transcript
10 Nov 19
2019 Q2
Earnings call transcript
10 Aug 19
2019 Q1
Earnings call transcript
4 May 19

Reddit threads

View all